Colistin sulfate 3 mg / neomycin sulfate 3.3 mg / thonzonium bromide 0.5 mg / hydrocortisone acetate 10 mg in 1 mL Otic Suspension
RxNorm 854992
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 854992 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: colistin sulfate 3 mg / neomycin sulfate 3.3 mg / thonzonium bromide 0.5 mg / hydrocortisone acetate 10 mg in 1 mL Otic Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Colistin 3 mg/ML / hydrocortisone 10 mg/ML / neomycin 3.3 mg/ML / thonzonium bromide 0.5 mg/ML Otic Suspension
(Atom ID: 12334442)
SYPrescribable
Synonym (SY):
Colistin 0.3 % / hydrocortisone 1 % / neomycin 0.33 % / thonzonium bromide 0.05 % Otic Suspension
(Atom ID: 3629248)
PSNPrescribable